- Home
- MTG vs BPMC Comparison
MTG vs BPMC Comparison
Compare MTG & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTG
- BPMC
- Stock Information
- Founded
- MTG 1957
- BPMC 2008
- Country
- MTG United States
- BPMC United States
- Employees
- MTG N/A
- BPMC N/A
- Industry
- MTG Property-Casualty Insurers
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- MTG Finance
- BPMC Health Care
- Exchange
- MTG Nasdaq
- BPMC Nasdaq
- Market Cap
- MTG 6.4B
- BPMC 5.8B
- IPO Year
- MTG 1991
- BPMC 2015
- Fundamental
- Price
- MTG $28.52
- BPMC $128.35
- Analyst Decision
- MTG Hold
- BPMC Buy
- Analyst Count
- MTG 8
- BPMC 20
- Target Price
- MTG $26.63
- BPMC $127.82
- AVG Volume (30 Days)
- MTG 2.3M
- BPMC 3.6M
- Earning Date
- MTG 07-30-2025
- BPMC 07-31-2025
- Dividend Yield
- MTG 1.82%
- BPMC N/A
- EPS Growth
- MTG 15.33
- BPMC N/A
- EPS
- MTG 3.00
- BPMC N/A
- Revenue
- MTG $1,219,604,000.00
- BPMC $562,121,000.00
- Revenue This Year
- MTG $2.92
- BPMC $44.46
- Revenue Next Year
- MTG $3.14
- BPMC $32.78
- P/E Ratio
- MTG $9.49
- BPMC N/A
- Revenue Growth
- MTG 4.64
- BPMC 99.19
- 52 Week Low
- MTG $21.20
- BPMC $73.04
- 52 Week High
- MTG $28.67
- BPMC $128.52
- Technical
- Relative Strength Index (RSI)
- MTG 67.39
- BPMC 74.59
- Support Level
- MTG $26.13
- BPMC $128.06
- Resistance Level
- MTG $28.35
- BPMC $128.52
- Average True Range (ATR)
- MTG 0.51
- BPMC 0.28
- MACD
- MTG 0.09
- BPMC -1.18
- Stochastic Oscillator
- MTG 94.09
- BPMC 74.44
About MTG MGIC Investment Corporation
MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.